Your browser doesn't support javascript.
loading
Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction.
Korjian, Serge; Kazmi, Syed Hassan A; Chi, Gerald; Kalayci, Arzu; Lee, Jane J; Talib, Usama; Wright, Samuel D; Duffy, Danielle; Kingwell, Bronwyn A; Mehran, Roxana; Ridker, Paul M; Gibson, C Michael.
Affiliation
  • Korjian S; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Kazmi SHA; North Shore Medical Center, Boston, MA, USA.
  • Chi G; North Shore Medical Center, Boston, MA, USA.
  • Kalayci A; North Shore Medical Center, Boston, MA, USA.
  • Lee JJ; Baim Institute for Clinical Research, Boston, MA, USA.
  • Talib U; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Wright SD; CSL Behring, King of Prussia, PA, USA.
  • Duffy D; CSL Behring, King of Prussia, PA, USA.
  • Kingwell BA; CSL Ltd, Bio21 Institute, Parkville, Australia.
  • Mehran R; Cardiovascular Institute, Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ridker PM; Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Gibson CM; North Shore Medical Center, Boston, MA, USA.
Eur Heart J Cardiovasc Pharmacother ; 9(4): 387-398, 2023 06 02.
Article in En | MEDLINE | ID: mdl-36787889
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plaque, Atherosclerotic / Myocardial Infarction Type of study: Clinical_trials Limits: Humans Language: En Journal: Eur Heart J Cardiovasc Pharmacother Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plaque, Atherosclerotic / Myocardial Infarction Type of study: Clinical_trials Limits: Humans Language: En Journal: Eur Heart J Cardiovasc Pharmacother Year: 2023 Document type: Article Affiliation country: Country of publication: